NIKKEI 225
27,402.05 +55.17 (+0.20%) HANG SENG
21,958.36 -113.82 (-0.52%) CRUDE OIL
75.68 -0.73 (-0.96%) GOLD FUTURES
1,927.90 -14.90 (-0.77%) DOW
33,865.91 -227.05 (-0.67%) BTC-GBP
19,455.50 +479.96 (+2.53%)
NVO Jan 2024 70.000 call
| Previous close | 36.20 |
| Open | 42.00 |
| Bid | 41.30 |
| Ask | 46.00 |
| Strike | 70.00 |
| Expiry date | 2024-01-19 |
| Day's range | 42.00 - 42.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 69 |
- Globe Newswire
Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 2 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their
- Zacks
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
Merck (MRK) beats Q4 estimates for earnings and sales. Its 2023 profit guidance disappoints. Stock declines in pre-market.
- Motley Fool
Novo Nordisk A/s (NVO) Q4 2022 Earnings Call Transcript
My name is Lars Fruergaard Jorgensen, and I'm the CEO of Novo Nordisk. With me today, I have executive vice president and head of commercial strategy and corporate affairs, Camilla Sylvest; executive vice president and head of North America operations, Doug Langa; executive vice president and head of development, Martin Holst Lange; and finally, chief financial officer, Karsten Munk Knudsen.
